Seeking Alpha

Pluristem receives patent in Russia

  • Russia's Federal Service for Intellectual Property grants Pluristem Therapeutics (PSTI) patent no. 2515156 entitled "Methods of Treating Inflammatory Colon Diseases." The patent covers methods to treat ulcerative colitis (Crohn's Disease) using placenta-derived cells.
  • South Africa has already issued the company a patent on the process. Decisions in several other jurisdictions are pending.
Comments (3)
  • PalmDesertRat
    , contributor
    Comments (2757) | Send Message
    that ticker is for the inverse T-Bonds.
    19 Jun, 08:29 AM Reply Like
  • LostOkie51
    , contributor
    Comments (65) | Send Message
    Hello PDR,
    They may have corrected a mistake since your comment
    but PSTI is indeed the stock symbol for Pluristem.
    19 Jun, 07:13 PM Reply Like
  • PalmDesertRat
    , contributor
    Comments (2757) | Send Message
    They changed it: it was orignally shown as PST
    19 Jun, 07:28 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: